Company PT Diagnos Laboratorium Utama Tbk

Equities

DGNS

ID1000158702

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Medical & Diagnostic Laboratories

End-of-day quote INDONESIA S.E. Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
206 ^IDR	-4.63%		-1.90%	-16.26%

16/05	PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04/03	PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI

PT Diagnos Laboratorium Utama Tbk is an Indonesia-based company that is engaged in providing health services using laboratories. The Companyâs scope of activities also includes private clinical activities. Its products and services include clinical pathology laboratory tests, anatomical pathology laboratory tests, genomics laboratory tests, homecare health tests, corporate health tests and Covid-19 tests. Its clinical pathology laboratory provides services ranging from molecular examinations to support more treatment. Its clinical pathology laboratory provides services for examination of hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology and microbiology. The services provided at the genetic laboratory are non-invasive prenatal testing (NIPT), preimplantation genetic testing for aneuploidy (PGT-A) services, and preimplantation genetic testing for monogenic diseases (PGT-M) services. Its homecare health services provide health checks that are done at home.

Number of employees: 96

IDR in Million	2022	Weight	2023	Weight	Delta
Doctor Referrals 76.6 %	129,185	67.0 %	111,626	76.6 %	-13.59%
Corporate Clients 14.5 %	49,053	25.4 %	21,055	14.5 %	-57.08%
Walk in Customers 8.9 %	14,648	7.6 %	13,015	8.9 %	-11.15%

IDR in Million	2022	Weight	2023	Weight	Delta
Indonesia 100.0 %	192,886	100.0 %	145,696	100.0 %	-24.47%

Managers	Title	Age	Since
Mesha Rizal Sini CEO	Chief Executive Officer	50	13/20/13
Fergus Richard DFI	Director of Finance/CFO	33	20/22/20
Dilly Dwiasri COO	Chief Operating Officer	47	20/22/20
Martinus Eliatulo Zega BRD	Director/Board Member	53	30/23/30
Fanfan Riksani IRC	Investor Relations Contact	49	14/20/14
Maurina Dwiyanthi AUD	Comptroller/Controller/Auditor	34	01/22/01
Dennis Jacobus PRN	Corporate Officer/Principal	36	13/20/13
Renobulan Rizal Sini Suheimi PRN	Corporate Officer/Principal	49	01/07/01

Members of the board	Title	Age	Since
Ivan Rizal Sini CHM	Chairman	52	13/20/13
Nurhadi Yudiyantho BRD	Director/Board Member	54	13/20/13
Martinus Eliatulo Zega BRD	Director/Board Member	53	30/23/30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,250,000,000	250,000,000 ( 20.00 %)	0	20.00 %

Name	Equities	%	Valuation
PT BUNDAMEDIK TBK 41.20 %	515,000,000	41.20 %	7 M Rp
Pt Bunda Investama Indonesia 38.80 %	485,000,000	38.80 %	7 M Rp

PT Diagnos Laboratorium Utama Tbk

Gedung Graha Anam Lantai 2 Jalan Cikditiro No. 11 A, B, C

10350, Jakarta

http://www.diagnos.co.id

address PT Diagnos Laboratorium Utama Tbk(DGNS)

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
PT DIAGNOS LABORATORIUM UTAMA TBK	-16.26%	16.49M
SONIC HEALTHCARE LIMITED	-18.02%	8.42B
RADNET, INC.	+70.38%	4.35B
DR. LAL PATHLABS LIMITED	+7.88%	2.74B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-56.54%	1.78B
NEOGENOMICS, INC.	-15.76%	1.7B
FLEURY S.A.	-16.46%	1.47B
METROPOLIS HEALTHCARE LIMITED	+17.87%	1.19B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-49.60%	1.03B
ADICON HOLDINGS LIMITED	-21.78%	927M

Medical & Diagnostic Laboratories